47192000: Meglumine amidotrizoate (substance)

SNOMED CT Concept\Substance\...

\Diagnostic substance (substance)\Contrast media (substance)\...

\Iodinated contrast media (substance)\Iodinated radiographic imaging contrast media\Ionic iodinated radiographic imaging contrast media\Ionic high-osmolality iodinated radiographic imaging contrast media\Amidotrizoate\Meglumine amidotrizoate

\Radiographic imaging contrast media (substance)\Iodinated radiographic imaging contrast media\Ionic iodinated radiographic imaging contrast media\Ionic high-osmolality iodinated radiographic imaging contrast media\Amidotrizoate\Meglumine amidotrizoate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Halogen and/or halogen compound\Iodine and/or iodine compound\Iodine compound\Iodinated contrast media (substance)\Iodinated radiographic imaging contrast media\Ionic iodinated radiographic imaging contrast media\Ionic high-osmolality iodinated radiographic imaging contrast media\Amidotrizoate\Meglumine amidotrizoate

\Organic compound\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Benzoic acid and/or benzoic acid derivative (substance)\Benzoate derivative (substance)\Amidotrizoate\Meglumine amidotrizoate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Meglumine amidotrizoate	Is a	røntgenkontraststof	false	Inferred relationship	Some
Meglumine amidotrizoate	Is a	Diagnostic substance (substance)	false	Inferred relationship	Some
Meglumine amidotrizoate	Is a	Radiopaque agent	false	Inferred relationship	Some
Meglumine amidotrizoate	Is a	Benzoate derivative (substance)	false	Inferred relationship	Some
Meglumine amidotrizoate	Is a	Amidotrizoate	true	Inferred relationship	Some
Meglumine amidotrizoate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Amidotrizoic acid	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
meglumindiatrizoat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some	1
meglumindiatrizoat + natriumdiatrizoat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some	2
diatrizoatmeglumin 66 %/natriumdiatrizoat 10 % opløsning, flaske a 120 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 30 % opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 520 mg + diatrizoatnatrium 80 mg opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 527 mg + iodipamidmeglumin 268 mg injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 50 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 300 mg + iod 141 mg/ml (30 %) injektionsvæske, opløsning, flaske a 300 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 180 mg + iod 85 mg/ml (18 %) injektionsvæske, opløsning, flaske a 300 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 2000 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1000 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1500 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 300 mg + iod 141 mg/ml (30 %) injektionsvæske, opløsning, hætteglas a 50 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1250 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 150 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 20 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 200 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 100 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
diatrizoatmeglumin 66 %/natriumdiatrizoat 10 % opløsning, flaske a 240 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some
Product containing meglumine diatrizoate in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some	1
Diatrizoate meglumine 66%/sodium diatrizoate 10% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Meglumine amidotrizoate	Inferred relationship	Some

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
78660012	Meglumine diatrizoate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
78661011	Diatrizoate meglumine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2620869014	Meglumine amidotrizoate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3713672017	Meglumine amidotrizoate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3255051000005110	meglumindiatrizoat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)